314
Views
18
CrossRef citations to date
0
Altmetric
Research Article

The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review

, M.D. & , M.D., D.M.Sc.
Pages 153-163 | Accepted 24 Nov 2009, Published online: 21 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ulla Knorr, Pernille Koefoed, Christian Gluud, Jørn Wetterslev, Per Winkel, Ulrik Gether, Maj Vinberg & Lars V. Kessing. (2016) Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression – a secondary outcome analysis from the randomized AGENDA trial. Nordic Journal of Psychiatry 70:4, pages 297-302.
Read now
Jerome C Wakefield. (2012) DSM-5: proposed changes to depressive disorders. Current Medical Research and Opinion 28:3, pages 335-343.
Read now

Articles from other publishers (16)

Benjamin Berger, Rüdiger Kornberger & Jasper Dingemanse. (2021) Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects. European Neuropsychopharmacology 51, pages 90-104.
Crossref
Sunday Yinka Olatunji, Iheanyichukwu Okoro, Joshua Oladele Owolabi, John Afees Olanrewaju, Stephen Taiye Adelodun & Sunday Oluseyi Fabiyi. (2021) Garcinia kola Attenuates MDMA-Induced Neuroinflammation in the CA1 Region of the Hippocampus in the Rat Model . Annals of Neurosciences 27:3-4, pages 104-113.
Crossref
Lixing Chen, Zengyu Yao, Shanshan Qu, Jialing Zhang, Jiping Zhang, Zhinan Zhang, Yong Huang & Zheng Zhong. (2020) Electroacupuncture improves synaptic plasticity by regulating the 5-HT1A receptor in hippocampus of rats with chronic unpredictable mild stress. Journal of International Medical Research 48:5, pages 030006052091841.
Crossref
Stephanie N. Mullins‐Sweatt, Christopher J. Hopwood, Michael Chmielewski, Neil A. Meyer, Jiwon Min, Ashley C. Helle & Maggie D. Walgren. (2019) Treatment of personality pathology through the lens of the hierarchical taxonomy of psychopathology: Developing a research agenda. Personality and Mental Health 14:1, pages 123-141.
Crossref
Jon Lansner, Christian G. Jensen, Anders Petersen, Patrick M. Fisher, Vibe G. Frokjaer, Signe Vangkilde & Gitte M. Knudsen. (2019) Three weeks of SSRI administration enhances the visual perceptual threshold - a randomized placebo-controlled study. Psychopharmacology 236:6, pages 1759-1769.
Crossref
Annette B. Brühl, Camilla d’Angelo & Barbara J. Sahakian. (2019) Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?. Brain and Neuroscience Advances 3, pages 239821281881601.
Crossref
Andreas Ø Bielefeldt, Pia B Danborg & Peter C Gøtzsche. (2016) Precursors to suicidality and violence on antidepressants: systematic review of trials in adult healthy volunteers. Journal of the Royal Society of Medicine 109:10, pages 381-392.
Crossref
Agorastos Agorastos, Michael Kellner, Oliver Stiedl, Christoph Muhtz, Klaus Wiedemann & Cüneyt Demiralay. (2015) Blunted autonomic reactivity to pharmacological panic challenge under long-term escitalopram treatment in healthy men. International Journal of Neuropsychopharmacology 18:5.
Crossref
Mohamed A. El-Nabarawi, Ehab R. Bendas, Randa Tag A. El Rehem & Mohammed Y.S. Abary. (2013) Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. International Journal of Pharmaceutics 443:1-2, pages 307-317.
Crossref
Douglas B. Samuel & Whitney L. Gore. (2012) Maladaptive Variants of Conscientiousness and Agreeableness. Journal of Personality 80:6, pages 1669-1696.
Crossref
Ulla Knorr, Maj Vinberg, Ulrik Gether, Per Winkel, Christian Gluud, Jørn Wetterslev & Lars Vedel Kessing. (2012) The effect of escitalopram versus placebo on perceived stress and salivary cortisol in healthy first-degree relatives of patients with depression—A randomised trial. Psychiatry Research 200:2-3, pages 354-360.
Crossref
Pekka Jylhä, Mikko Ketokivi, Outi Mantere, Tarja Melartin, Mikael Holma, Heikki Rytsälä & Erkki Isometsä. (2012) Do antidepressants change personality?—A five-year observational study. Journal of Affective Disorders 142:1-3, pages 200-207.
Crossref
Ulla Knorr, Maj Vinberg, Erik Lykke Mortensen, Per Winkel, Christian Gluud, Jørn Wetterslev, Ulrik Gether & Lars Vedel Kessing. (2012) Effect of Chronic Escitalopram versus Placebo on Personality Traits in Healthy First-Degree Relatives of Patients with Depression: A Randomized Trial. PLoS ONE 7:2, pages e31980.
Crossref
Ulla Knorr, Maj Vinberg, Anders Gade, Per Winkel, Christian Gluud, Jørn Wetterslev, Ulrik Gether & Lars Kessing. (2011) A randomized trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression . Therapeutic Advances in Psychopharmacology 1:5, pages 133-144.
Crossref
Joseph M. Pierre. (2010) The Borders of Mental Disorder in Psychiatry and the DSM. Journal of Psychiatric Practice 16:6, pages 375-386.
Crossref
Thierry Favrod-Coune & Barbara Broers. (2010) The Health Effect of Psychostimulants: A Literature Review. Pharmaceuticals 3:7, pages 2333-2361.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.